Leishmania donovanitargets tumor necrosis factor receptor‐associated factor (TRAF) 3 for impairing TLR4‐mediated host response
Lipopolysaccharides
0301 basic medicine
Mice, Inbred BALB C
TNF Receptor-Associated Factor 3
Reverse Transcriptase Polymerase Chain Reaction
Lysine
Macrophages
Immunoblotting
Models, Immunological
NF-kappa B
Gene Expression
Interleukin-12
Cell Line
Host-Parasite Interactions
3. Good health
Mice
03 medical and health sciences
Animals
Leishmaniasis, Visceral
RNA Interference
Cells, Cultured
Leishmania donovani
Signal Transduction
DOI:
10.1096/fj.13-238428
Publication Date:
2014-01-04T01:20:17Z
AUTHORS (7)
ABSTRACT
Intramacrophage pathogen Leishmania donovani escapes host immune response by subverting Toll-like receptor (TLR) signaling, which is critically regulated protein ubiquitination. In the present study, we identified tumor necrosis factor receptor-associated (TRAF) 3, degradative ubiquitination of essential for TLR4 activation, as a target to deactivate LPS-mediated signaling. We used LPS-treated RAW 264.7 cells and compared TLR4-mediated in these with L. + LPS costimulated macrophages. TRAF3, was ubiquitinated (2.1-fold over control) at lys 48 position subsequently degraded following treatment, persisted due defective Lys 63-linked upstream proteins cascade (cIAP1/2 TRAF6), mandatory TRAF3 degradation, also reduced postinfection. This may be attributed association between ubiquitin-conjugating enzyme Ubc13 TRAF6 during infection. Inhibition before infection shRNA Balb/c mice showed enhanced IL-12 TNF-α (10.8- 8.1-fold infected decreased spleen parasite burden (61.3% suppression, P<0.001), thereby marking reduction disease progression. Our findings novel molecular regulator exploited successful infection.—Gupta, P., Giri, J., Srivastav, S., Chande, A. G., Mukhopadhyaya, R., Das, P. K., Ukil, targets 3 impairing response. FASEB J. 28, 28–1756 (1768). www.fasebj.org
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (29)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....